Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Neoadjuvant Therapy for HR+ Breast Cancer 

The Role of Fulvestrant in HR+ Breast Cancer 

Abemaciclib for HR-Positive Metastatic Breast Cancer 

Quality of Life for Women with HR-Positive Breast Cancer 

MONALEESA-7 Trial in Premenopausal HR+ Breast Cancer 

Aditya Bardia, MD, MPH, assistant professor of medicine, Harvard Medical School, attending physician, Medical Oncology, Massachusetts General Hospital, discusses the role of the microenvironment in the treatment of metastatic triple-negative breast cancer (TNBC).

Dr. Bardia on the Role of the Microenvironment in TNBC

Hope S. Rugo, MD, discusses the importance of individualizing doses of nab-paclitaxel in triple-negative breast cancer. 

Findings Support Nab-Paclitaxel as Top Choice for First-Line TNBC Therapy

Prudence Francis, MD, Peter MacCallum Cancer Centre, discusses ovarian suppression in young women with hormone receptor (HR)-positive breast cancer.

Dr. Francis on Ovarian Suppression in Young Women With Breast Cancer

Other Promising Targets in TNBC

Role of the Androgen Receptor in TNBC

Combination Therapy for TNBC: Checkpoint Inhibitor + Chemotherapy

Checkpoint Inhibitor Monotherapy for TNBC

Antibody-Drug Conjugates in Treating TNBC

Paclitaxel vs Nab-Paclitaxel in Metastatic TNBC

No pCR in Patients After Neoadjuvant Chemotherapy in TNBC

Anthracycline-Based Regimens: Perioperative Setting for TNBC

Neoadjuvant Therapy in TNBC

Combining PARP Inhibitors + Checkpoint Inhibitors in TNBC

Sequencing in BRCA-Positive TNBC Patients

NCCN Guideline Changes for BRCA Testing in TNBC

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Breast Cancer

Breast Cancer | Specialty